TCIM
FATE icon

TIAA CREF Investment Management’s Fate Therapeutics FATE Stock Holding History

TIAA CREF Investment Management’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$1.76M Sell
99,950
-389
-0.4% -$6.14K ﹤0.01% 2066
2018
Q4 		$1.29M Buy
100,339
+7,197
+8% +$100K ﹤0.01% 2188
2018
Q3 		$1.52M Sell
93,142
-4,063
-4% -$48K ﹤0.01% 2253
2018
Q2 		$1.1M Sell
97,205
-5,968
-6% -$65.7K ﹤0.01% 2453
2018
Q1 		$1.01M Buy
103,173
+6,911
+7% +$66.2K ﹤0.01% 2442
2017
Q4 		$588K Sell
96,262
-5,759
-6% -$25.7K ﹤0.01% 2706
2017
Q3 		$404K Sell
102,021
-13,254
-11% -$45.1K ﹤0.01% 2920
2017
Q2 		$373K Buy
+115,275
New +$442K ﹤0.01% 2988

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return